Large and comprehensive genomic surveys of head and neck squamous cell carcinomas are now greatly increasing our understanding of the diversity of this disease and the key genomic changes, which drive these tumors. The results from these studies are beginning to inform the introduction of novel therapies for patients with head and neck squamous cell cancers. Here, we review some of the key findings from recent genomic studies of head and neck cancers including the most comprehensive study to date from The Cancer Genome Atlas Network
Head and neck cancer affects nearly 750,000 patients, with more than 300,000 deaths annually. Advanc...
Recent genomic sequencing studies have provided valuable insight into genetic aberrations in head an...
2012 August 09 Author ManuscriptHead and neck squamous cell carcinoma (HNSCC) is a common, morbid, a...
Large and comprehensive genomic surveys of head and neck squamous cell carcinomas are now greatly in...
Large and comprehensive genomic surveys of head and neck squamous cell carcinomas (HNSCC) are now gr...
AbstractThe past decade has seen an unprecedented increase in our understanding of the biology and e...
International audienceHead and neck squamous cell carcinomas (HNSCC) represent a multifactorial dise...
Item does not contain fulltextPersonalised medicine tumour boards, which leverage genomic data to im...
Head and neck squamous cell carcinoma (HNSCC) remains a common and deadly disease. Historically, sur...
The Cancer Genome Atlas profiled 279 head and neck squamous cell carcinomas (HNSCCs) to provide a co...
Despite improvements in functional outcomes attributable to advances in radiotherapy, chemotherapy, ...
Head and neck squamous cell carcinoma (HNSCC), is a cancer of the upper aerodigestive tract epitheli...
Abstract: Advances in gene expression analyses have allowed global assessment of expressed genes in ...
Head and neck cancer is the fifth most common cancer worldwide. It is often amenable to curative int...
Genomic instability underlies the transformation of host cells toward malignancy, promotes developme...
Head and neck cancer affects nearly 750,000 patients, with more than 300,000 deaths annually. Advanc...
Recent genomic sequencing studies have provided valuable insight into genetic aberrations in head an...
2012 August 09 Author ManuscriptHead and neck squamous cell carcinoma (HNSCC) is a common, morbid, a...
Large and comprehensive genomic surveys of head and neck squamous cell carcinomas are now greatly in...
Large and comprehensive genomic surveys of head and neck squamous cell carcinomas (HNSCC) are now gr...
AbstractThe past decade has seen an unprecedented increase in our understanding of the biology and e...
International audienceHead and neck squamous cell carcinomas (HNSCC) represent a multifactorial dise...
Item does not contain fulltextPersonalised medicine tumour boards, which leverage genomic data to im...
Head and neck squamous cell carcinoma (HNSCC) remains a common and deadly disease. Historically, sur...
The Cancer Genome Atlas profiled 279 head and neck squamous cell carcinomas (HNSCCs) to provide a co...
Despite improvements in functional outcomes attributable to advances in radiotherapy, chemotherapy, ...
Head and neck squamous cell carcinoma (HNSCC), is a cancer of the upper aerodigestive tract epitheli...
Abstract: Advances in gene expression analyses have allowed global assessment of expressed genes in ...
Head and neck cancer is the fifth most common cancer worldwide. It is often amenable to curative int...
Genomic instability underlies the transformation of host cells toward malignancy, promotes developme...
Head and neck cancer affects nearly 750,000 patients, with more than 300,000 deaths annually. Advanc...
Recent genomic sequencing studies have provided valuable insight into genetic aberrations in head an...
2012 August 09 Author ManuscriptHead and neck squamous cell carcinoma (HNSCC) is a common, morbid, a...